Argent BioPharma Limited (ASX:RGT)

Argent BioPharma Revenue

In the fiscal year ending June 30, 2026, Argent BioPharma had annual revenue of 161.19K AUD, down -10.73%. Argent BioPharma had revenue of -10.31K in the half year ending June 30, 2026. That makes Argent BioPharma the 46,002nd largest company in the world by revenue and 1,214th in Australia.

• Revenue: 161.19K
• Revenue Growth: -10.73%
• P/S Ratio: 13.89
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 2.24M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	161.19K	-19.38K	-10.73%
Jun 30, 2025	180.57K	-710.52K	-79.74%
Jun 30, 2024	891.08K	-2.50M	-73.70%
Jun 30, 2023	3.39M	-1.34M	-28.41%
Jun 30, 2022	4.73M	1.74M	57.94%

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 5, 2026

Data Sources Report a data error